Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:217-26.
Epub 2011 Oct 22.

Predicting adverse drug events from personal health messages

Affiliations

Predicting adverse drug events from personal health messages

Brant W Chee et al. AMIA Annu Symp Proc. 2011.

Abstract

Adverse drug events (ADEs) remain a large problem in the United States, being the fourth leading cause of death, despite post market drug surveillance. Much post consumer drug surveillance relies on self-reported "spontaneous" patient data. Previous work has performed datamining over the FDA's Adverse Event Reporting System (AERS) and other spontaneous reporting systems to identify drug interactions and drugs correlated with high rates of serious adverse events. However, safety problems have resulted from the lack of post marketing surveillance information about drugs, with underreporting rates of up to 98% within such systems. We explore the use of online health forums as a source of data to identify drugs for further FDA scrutiny. In this work we aggregate individuals' opinions and review of drugs similar to crowd intelligence3. We use natural language processing to group drugs discussed in similar ways and are able to successfully identify drugs withdrawn from the market based on messages discussing them before their removal.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Illustration of how Yahoo! messages are divided and used by multiple classifiers in a bagging approach.

References

    1. Fletcher AP. Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. Journal of the Royal Society of Medicine. 1991;84(6):341. - PMC - PubMed
    1. McClellan M. Drug Safety Reform at the FDA—Pendulum Swing or Systematic Improvement? New England Journal of Medicine. 2007;356(17):1700–1702. - PubMed
    1. Surowiecki J. The wisdom of crowds: Why the many are smarter than the few and how collective wisdom shapes business, economies, societies, and nations. Random House of Canada; 2004.
    1. Harpaz R, Haerian K, Chase HS, Friedman C. Statistical Mining of Potential Drug Interaction Adverse Effects in FDA’s Spontaneous Reporting System. AMIA Annual Symposium Proceedings. 2010;2010:281. - PMC - PubMed
    1. Anon Making a difference. Nat Biotechnol. 2009;27(4):297–297. - PubMed

MeSH terms

LinkOut - more resources